It is a pharma private limited company based in Kolkata, West Bengal, India, established in 1993.
1993 | Kolkata, West Bengal, India | ActiveDrakt Pharmaceuticals Pvt Ltd, a active private limited company, was established on 12 May 1993 in Kolkata, West Bengal, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232WB1993PTC058790. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹8.95 M.
It upholds a active non-compliant status. Employing 61 professional, Its leadership includes Swapan Kumar Saha Roy (Director), Sanjoy Kumar Paul (Director), Bibhas Saha (Director). It holds ₹0.55 M open charges and ₹7.10 Cr settled loans. Its latest AGM occurred on 30 September 2019, with the balance sheet filed on 31 March 2019. It is based at Diamond Har Bour Roadjoka, Kolkata, West Bengal, 700104.
U24232WB1993PTC058790
058790
12 May 1993
₹1.00 Cr
₹8.95 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Drakt Pharmaceuticals Pvt Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Swapan Kumar Saha Roy | Director | 19 May 1998 | Current |
| Sanjoy Kumar Paul | Director | 12 May 1993 | Current |
| Bibhas Saha | Director | 12 May 1993 | Current |
| Jiban Kumar Saha | Director | 28 Sep 1994 | Current |
| Kanchan Kumar Ghosal | Director | 28 Sep 1994 | Current |
| Rana Dasgupta | Director | 12 May 1993 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Drakt Pharmaceuticals Pvt Ltd, for the financial year ended 2019, experienced significant reduction in revenue, with a 24.43% decrease. The company also saw a substantial fall in profitability, with a 233.2% decrease in profit. The company's net worth dipped by a decrease of 5.63%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Drakt Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹554,000.00
₹70,982,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 Apr 2019 | State Bank Of India | ₹0.55 M | Open |
| 24 Sep 2011 | State Bank Of India | ₹1.54 Cr | Satisfied |
| 14 Sep 2007 | State Bank Of India | ₹1.54 Cr | Satisfied |
| 18 May 2006 | State Bank Of India | ₹9.15 M | Satisfied |
| 18 Oct 2004 | State Bank Of India | ₹3.00 M | Satisfied |
Explore comprehensive loan charge details -
Drakt Pharmaceuticals has a workforce of 61 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Drakt Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Drakt Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 03 Mar 2004 via Charge ID 80038000 with State Bank Of India was fully satisfied on 09 Dec 2020. was completed.
The activity Drakt Pharmaceuticals Pvt Ltd last Annual general meeting of members was held on 30 Sep 2019 as per latest MCA records. was completed.
Progress on A charge with State Bank Of India amounted to Rs. 0.06 Cr with Charge ID 100254721 was registered on 09 Apr 2019. was documented.
Progress on Drakt Pharmaceuticals Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Kolkata. was documented.
The activity A charge with State Bank Of India of Rs. 2.20 Cr registered on 03 Mar 2004 with Charge ID 80038000 was modified on 20 Apr 2017. was completed.
Progress on A charge registered on 24 Sep 2011 via Charge ID 10365227 with State Bank Of India was fully satisfied on 15 Jun 2016. was documented.
The CIN of Drakt Pharmaceuticals Pvt Ltd is U24232WB1993PTC058790.
Drakt Pharmaceuticals Pvt Ltd is headquartered at Diamond Har Bour Roadjoka, Kolkata, West Bengal, 700104.
Drakt Pharmaceuticals Pvt Ltd was incorporated on 12 May 1993.
The current directors of Drakt Pharmaceuticals Pvt Ltd are
The primary industry of Drakt Pharmaceuticals Pvt Ltd is Manufacturing.
Drakt Pharmaceuticals Pvt Ltd is unlisted.
The authorized capital of Drakt Pharmaceuticals Pvt Ltd is ₹1.00 Cr, and the paid-up capital is ₹8.95 M.
The compliance status of Drakt Pharmaceuticals Pvt Ltd is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX